Home
>
National Drug Code (NDC)
>
Haemonetics Anticoagulant Citrate Dextrose Solution
Haemonetics Anticoagulant Citrate Dextrose Solution - 57826-426-04 - (ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, DEXTROSE MONOHYDRATE)
Drug Information of Haemonetics Anticoagulant Citrate Dextrose Solution
| Product NDC: | 57826-426 |
| Proprietary Name: | Haemonetics Anticoagulant Citrate Dextrose Solution |
| Non Proprietary Name: | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, DEXTROSE MONOHYDRATE |
| Active Ingredient(s): | 73; 245; 220 mg/mL; mg/mL; mg/mL & nbsp; ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, DEXTROSE MONOHYDRATE |
| Administration Route(s): | EXTRACORPOREAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Haemonetics Anticoagulant Citrate Dextrose Solution
| Product NDC: | 57826-426 |
| Labeler Name: | Haemonetics Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA980728 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20130110 |
Package Information of Haemonetics Anticoagulant Citrate Dextrose Solution
| Package NDC: | 57826-426-04 |
| Package Description: | 500 mL in 1 BAG (57826-426-04) |
NDC Information of Haemonetics Anticoagulant Citrate Dextrose Solution
| NDC Code | 57826-426-04 |
| Proprietary Name | Haemonetics Anticoagulant Citrate Dextrose Solution |
| Package Description | 500 mL in 1 BAG (57826-426-04) |
| Product NDC | 57826-426 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, DEXTROSE MONOHYDRATE |
| Dosage Form Name | SOLUTION |
| Route Name | EXTRACORPOREAL |
| Start Marketing Date | 20130110 |
| Marketing Category Name | BLA |
| Labeler Name | Haemonetics Corporation |
| Substance Name | ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
| Strength Number | 73; 245; 220 |
| Strength Unit | mg/mL; mg/mL; mg/mL |
| Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
